Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Receivables (2016 - 2025)

Historic Receivables for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $191.5 million.

  • Icu Medical's Receivables rose 1009.18% to $191.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $191.5 million, marking a year-over-year increase of 1009.18%. This contributed to the annual value of $182.8 million for FY2024, which is 1315.99% up from last year.
  • Per Icu Medical's latest filing, its Receivables stood at $191.5 million for Q3 2025, which was up 1009.18% from $179.5 million recorded in Q2 2025.
  • Icu Medical's 5-year Receivables high stood at $216.6 million for Q4 2022, and its period low was $105.9 million during Q4 2021.
  • For the 5-year period, Icu Medical's Receivables averaged around $164.9 million, with its median value being $162.2 million (2023).
  • As far as peak fluctuations go, Icu Medical's Receivables crashed by 3925.81% in 2021, and later skyrocketed by 10456.21% in 2022.
  • Icu Medical's Receivables (Quarter) stood at $105.9 million in 2021, then soared by 104.56% to $216.6 million in 2022, then fell by 25.41% to $161.6 million in 2023, then increased by 13.16% to $182.8 million in 2024, then rose by 4.77% to $191.5 million in 2025.
  • Its last three reported values are $191.5 million in Q3 2025, $179.5 million for Q2 2025, and $170.9 million during Q1 2025.